Home › Funds › Chevy Chase Trust Holdings, LLC › VRTX

Chevy Chase Trust Holdings, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Chevy Chase Trust Holdings, LLC reported holding 421,995 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$220.6M, representing 0.55% of its reported portfolio and ranking #27 among its reported holdings. Chevy Chase Trust Holdings, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)422.00K sh
Reported value held$220.62M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Chevy Chase Trust Holdings, LLC's VRTX position evolved

Chevy Chase Trust Holdings, LLC first disclosed a stake in VRTX in Q3 2023 at 430,638 shares (US$149.8M). The position peaked in Q3 2026 at 421,995 shares, worth US$220.6M. Across 13 filings, Chevy Chase Trust Holdings, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 421,995 shares valued at US$220.6M — an increase of 15,692 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 430.64K $149.75M New
Q4 2023 444.95K $181.05M Add
Q1 2024 443.82K $185.52M Hold
Q2 2024 453.43K $212.53M Add
Q3 2024 446.86K $207.83M Reduce
Q4 2024 444.70K $179.08M Hold
Q1 2025 443.05K $214.80M Hold
Q2 2025 440.93K $196.30M Hold
Q3 2025 418.51K $163.90M Reduce
Q4 2025 408.36K $185.14M Reduce
Q1 2026 407.62K $182.02M Hold
Q2 2026 406.30K $201.82M Hold
Q3 2026 422.00K $220.62M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Chevy Chase Trust Holdings, LLC held VRTX?

Chevy Chase Trust Holdings, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Chevy Chase Trust Holdings, LLC's current position in VRTX?

As of Q3 2026, Chevy Chase Trust Holdings, LLC holds 422.00K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $220.62M, representing 0.55% of its reported portfolio and ranking #27.

Has Chevy Chase Trust Holdings, LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Chevy Chase Trust Holdings, LLC increased its position in VRTX. The position peaked in Q3 2026 at 422.00K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.